The presence of an NPM1 mutation without concomitant FLT3-ITD (FMS-like tyrosine kinase 3-internal tandem duplication) in NK-AML patients has been associated with a favorable prognosis [9–11]. The gene discussed is FLT3; the disease is acute myeloid leukemia.